Dr. Jay Adam Lieberman, MD

  • Memphis, TN
  • Allergist and immunologist
NPI1407877004PAC ID5395992010
Part D claims, 2024
61
Publications
101
Clinical trials
4
Industry payments
$88,150
Affiliated sites
1
Practice address
850 Poplar Ave, Memphis, TN 38105
Practice phone
Call (901) 287-7337
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

UT Lebonheur Pediatric Specialists, Inc.

Memphis, Tennessee

See all 3 affiliations

Find Dr. Lieberman's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Jay Adam Lieberman is an allergist and immunologist in Memphis, Tennessee

Dr. Lieberman practices at UT Lebonheur Pediatric Specialists, Inc. in Memphis, Tennessee.

Dr. Lieberman's NPI, 1407877004, was assigned on July 21, 2006. Dr. Lieberman graduated from University of Tennessee, Hsc, College of Medicine in 2006. Dr. Lieberman holds Tennessee license 48645.

NPI and contact details
Medicare PAC ID
5395992010
NPI enumeration date
July 21, 2006
NPI status
Active
Accepts Medicare assignment
Yes
Practice phone
(901) 287-7337
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Male
Estimated age
46
Medical school graduation
2006

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Practice Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Jay Adam Lieberman practices at UT Lebonheur Pediatric Specialists, Inc. in Memphis, Tennessee

Dr. Lieberman's primary practice is UT Lebonheur Pediatric Specialists, Inc., at 850 Poplar Ave, Memphis, TN 38105 in Shelby County. The practice phone is (901) 287-7337.

  • UT Lebonheur Pediatric Specialists, Inc.
    850 Poplar Ave, Memphis, TN 38105 · Shelby CountyPhone(901) 287-7337

Sources: NPPES NPI Registry (CMS); and Dmand AI Practice Data

Dr. Jay Adam Lieberman is affiliated with 2 sites of care and 1 medical group

Dr. Lieberman's primary practice is UT Lebonheur Pediatric Specialists, Inc. in Memphis, Tennessee. The medical group on file is UT Le Bonheur Pediatric Specialists. Dmand AI also links Dr. Lieberman to 1 more group practice or clinic, named with a free account.

See all 3 affiliations for Dr. Lieberman

Sources: NPPES NPI Registry (CMS); Dmand AI Practice Data; and Dmand AI Affiliation Data

Dmand AI tracks the EHR system at Dr. Jay Adam Lieberman's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lieberman practices. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
UT Lebonheur Pediatric Specialists, Inc.Available with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every site where Dr. Lieberman practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across each health system and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Jay Adam Lieberman is one of 72 allergists and immunologists in Tennessee

Allergy and immunology is Dr. Lieberman's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Dmand AI has Dr. Lieberman's licenses on file in 3 states: Tennessee, Missouri and New York.

Specialties and state licenses

  • Allergy and immunology, TennesseePrimaryLicense 48645 · taxonomy 207K00000X
  • Internal medicine, MissouriLicense 2006015608 · taxonomy 207R00000X
  • New York licenseLicense 254120-1

Allergists and immunologists near Dr. Lieberman

Counts of allergists and immunologists with a Dmand AI profile, by place and practice. Each opens the list.

72allergists and immunologists in Tennessee
5allergists and immunologists in Memphis

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Jay Adam Lieberman's patients have a median age of 11

Across all payers, Dmand AI patient panel data puts Dr. Lieberman's median patient age at 11, with 41% women.

Dr. Lieberman's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 11

Patient panel by sex, all payers

  • Women41%
  • Men59%

Source: Dmand AI Patient Panel Data

Dr. Jay Adam Lieberman wrote 61 Medicare Part D claims in 2024

In 2024, Dr. Lieberman wrote 61 Medicare Part D claims. 54% of them were for generic drugs. CMS names the drug for 32 of them, across 2 drugs with 11 or more claims each, at $54,518 in total drug cost. In 2023, CMS named 39 claims across 2 drugs.

Part D claims, 202461
Drugs named by CMS2
Total drug cost$54,518

Dr. Lieberman's Part D claims by kind of drug, 2024

  • Generic33 claims54%
  • Brand-name28 claims46%

Dr. Lieberman's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 392024: 3218%

Drugs named by CMS: 2 in 2024, 2 in 2023.

See all prescribing by Dr. Lieberman

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

How Dr. Jay Adam Lieberman takes part in Medicare

Dr. Lieberman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Accepts Medicare assignment
Yes

Source: Doctors and Clinicians National Downloadable File (CMS)

For MedTech and pharma teams

Find allergists and immunologists like Dr. Lieberman by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Jay Adam Lieberman has 101 publications on record

Dmand AI links 101 papers to Dr. Lieberman, published from 2010 to 2025. 2024 was the busiest year, with 18. The most frequent topics are Anaphylaxis, Food Hypersensitivity and Epinephrine. Dr. Lieberman has published most often in Ann Allergy Asthma Immunol. Dr. Lieberman's most frequent co-authors are Matthew Jason Greenhawt, MBA, MD, John J. Oppenheimer, MD and David Robert Stukus, MD.

Papers101
Years published2010 to 2025

Dr. Lieberman's papers by year, 2014 to 2025

Topics Dr. Lieberman writes about most

  • Anaphylaxis
  • Food Hypersensitivity
  • Epinephrine
  • Allergens
  • Hypersensitivity
  • COVID-19
  • Immunoglobulin E
  • Injections, Intramuscular

Dr. Lieberman's most frequent co-authors

Recent publications by Dr. Lieberman

See all 101 publications and co-authors

See who Dr. Lieberman researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Lieberman works with, so you can find a warm path to the right allergists and immunologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Jay Adam Lieberman has worked on 4 clinical trials

Dmand AI links Dr. Lieberman to 4 clinical trials, 2 of them phase 3 studies. Conditions studied include Peanut Hypersensitivity, Nut and Peanut Hypersensitivity and Primary Immunodeficiency Diseases. Open Payments lists research payments to Dr. Lieberman that name 1 trial.

Conditions in Dr. Lieberman's trials

  • Peanut Hypersensitivity
  • Nut and Peanut Hypersensitivity
  • Primary Immunodeficiency Diseases
  • Severe combined immunodeficiency due to adenosine deaminase deficiency
  • Immunologic Deficiency Syndromes

Investigators on the most trials with Dr. Lieberman

Recent clinical trials with Dr. Lieberman

Sources: Open Payments (CMS), 2025 data, released July 7, 2026; Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Jay Adam Lieberman received $88,150 in industry payments from 2017 to 2025

CMS Open Payments shows 81 general payments to Dr. Lieberman from 17 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 69% of the total. Genentech, Inc. paid the most, $25,948. It also lists 12 research payments totaling $50,446 from 2019 to 2025, naming 1 clinical trial.

General payments to Dr. Lieberman by program year, 2017 to 2025

General payments to Dr. Lieberman by kind, 2017 to 2025

$88.1Kin total
  • Consulting fees$60,83869%
  • Honoraria$9,89611%
  • Speaker and faculty fees$8,54010%
  • Travel and lodging$6,1887%
  • Food and beverage$2,6873%

Companies that paid Dr. Lieberman the most, 2017 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Lieberman

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Jay Adam Lieberman graduated from University of Tennessee, Hsc, College of Medicine

Dr. Lieberman graduated from University of Tennessee, Hsc, College of Medicine in 2006.

  1. Medical schoolUniversity of Tennessee, Hsc, College of Medicine

Source: Dmand AI Professional Profile Data

Sources for Dr. Jay Adam Lieberman's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice Data
Primary practice, affiliations and health systemNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Practice DataDmand AI Affiliation Data
Medicare patients and the all-payer patient panelDmand AI Patient Panel Data
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Training, board certification and membershipsDmand AI Professional Profile Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Jay Adam Lieberman

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Jay Adam Lieberman's NPI number?

Dr. Jay Adam Lieberman's NPI number is 1407877004. It was assigned on July 21, 2006, and it is active in the NPI Registry.

What kind of doctor is Dr. Jay Adam Lieberman?

Dr. Jay Adam Lieberman is an allergist and immunologist in Memphis, Tennessee. The primary specialty in the NPI Registry is Allergy & Immunology Physician (taxonomy code 207K00000X).

Where does Dr. Jay Adam Lieberman practice?

Dr. Lieberman practices at 850 Poplar Ave, Memphis, TN 38105. Dr. Lieberman's primary practice is UT Lebonheur Pediatric Specialists, Inc. in Memphis, Tennessee. Dmand AI also links Dr. Lieberman to 1 group practice or clinic.

What is Dr. Jay Adam Lieberman's office phone number?

The practice phone on file for Dr. Lieberman is (901) 287-7337.

What is Dr. Jay Adam Lieberman's medical license number?

Dr. Lieberman holds Tennessee license 48645, one of the licenses on file in 3 states.

Which states has Dr. Jay Adam Lieberman been licensed in?

Dmand AI has state licenses on file for Dr. Lieberman in Tennessee, Missouri and New York.

What medical group is Dr. Jay Adam Lieberman part of?

Dr. Lieberman is linked to UT Le Bonheur Pediatric Specialists.

Does Dr. Jay Adam Lieberman accept Medicare?

Yes. CMS lists Dr. Lieberman as accepting Medicare assignment.

Where did Dr. Jay Adam Lieberman go to medical school?

Dr. Lieberman graduated from University of Tennessee, Hsc, College of Medicine in 2006.

What drugs does Dr. Jay Adam Lieberman prescribe most?

In 2024 Medicare Part D data, Dr. Lieberman's most prescribed drugs by claims were Xolair and Cromolyn Sodium.

Show 4 more questionsShow fewer questions

Has Dr. Jay Adam Lieberman received payments from drug or device companies?

CMS Open Payments shows $88,150 in general payments to Dr. Lieberman from 17 companies from 2017 to 2025. The largest total came from Genentech, Inc.

How long has Dr. Jay Adam Lieberman been practicing?

Dr. Lieberman graduated from medical school in 2006, 20 years ago.

Does Dr. Jay Adam Lieberman do research?

Dmand AI links 101 publications to Dr. Lieberman, published from 2010 to 2025. Dr. Lieberman has worked on 4 clinical trials.

Who does Dr. Jay Adam Lieberman publish with?

Dr. Lieberman's most frequent co-authors are Matthew Jason Greenhawt, MBA, MD (34 shared papers), John J. Oppenheimer, MD (19 shared papers) and David Robert Stukus, MD (19 shared papers).

Selling to allergy and immunology practices?

See allergists and immunologists in Tennessee by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)